智醫科學

AI醫療技術、應用與市場動態

【分子膠】《Bristol: BMY》將利用《VantAI》生成式AI來設計標靶蛋白質降解分子膠

 【分子膠】《Bristol: BMY》將利用《VantAI》生成式AI來設計標靶蛋白質降解分子膠


 文章出處  

PharmiWeb 

 

 原文標題  

VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence 

 

 Twitter  

https://twitter.com/aimedadviser/status/1759190739077210440 

 

 文章序號  

5089 

 

智醫科學-AI醫療技術、應用與市場動

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.